Durham, NC, United States of America

Stephon Cornell Smith

USPTO Granted Patents = 2 


Average Co-Inventor Count = 9.3

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2009-2012

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Stephon Cornell Smith

Introduction

Stephon Cornell Smith is a notable inventor based in Durham, NC (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that showcase his innovative spirit and dedication to advancing medical science.

Latest Patents

Smith's latest patents include the development of imidazopyridine kinase inhibitors. This invention provides imidazopyridine compounds, compositions containing these compounds, as well as processes for their preparation and methods for their use as pharmaceutical agents. Another significant patent is for benzimidazole thiophene compounds, which includes pharmaceutical compositions containing these compounds, processes for preparing them, and their use as pharmaceutical agents.

Career Highlights

Throughout his career, Smith has worked with prominent companies in the pharmaceutical industry, including SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has undoubtedly contributed to his expertise and innovative capabilities.

Collaborations

Some of his notable coworkers include Kevin Kuntz and Kyle Allen Emmitte. Their collaboration has likely fostered an environment of creativity and innovation, leading to the development of groundbreaking pharmaceutical solutions.

Conclusion

Stephon Cornell Smith's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…